Nuclidium
FranceWho owns Nuclidium?
Nuclidium is a French Pharma company, currently owned by Wellington Partners since 2026 and 4 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
- ·Co-held by NRW.BANK, DeepTech & Climate Fonds, Angelini Ventures, Neva SGR and Wellington Partners since 2025.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from Neva II
Other portfolio companies in the same fund.
United States
Switzerland
More PE-backed in Pharma
Comparable pharma deals from other GPs.
SpainQuestions
Who owns Nuclidium?
Nuclidium is currently owned by Wellington Partners, NRW.BANK and 3 others, through Neva II, since 2026.
When did Wellington Partners and 4 others acquire Nuclidium?
Wellington Partners and 4 others acquired Nuclidium in 2026.
Who has owned Nuclidium over time?
Nuclidium has been through 5 private-equity ownership periods: NRW.BANK · via NRW.Venture · since 2025; DeepTech & Climate Fonds · via DeepTech & Climate Fonds · since 2025; Angelini Ventures · via Angelini Ventures · since 2025; Neva SGR · via Neva II · since 2025; Wellington Partners · via Wellington Partners Life Sciences · since 2026.